Recent Research Advances in Nano-Based Drug Delivery Systems for Local Anesthetics
He Ma,Zhenxiang Pan,Bingjie Lai,Chunfang Zan,He Liu
DOI: https://doi.org/10.2147/dddt.s417051
2023-08-30
Abstract:He Ma, 1 Zhenxiang Pan, 1 Bingjie Lai, 2 Chunfang Zan, 3, 4 He Liu 5 1 Department of Anesthesiology, The Second Hospital of Jilin University, Changchun, People's Republic of China; 2 Department of Intensive Care Unit, The Second Hospital of Jilin University, Changchun, People's Republic of China; 3 Department of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China; 4 Collaborative Innovation Center for Molecular Imaging of Precision Medicine, Shanxi Medical University, Taiyuan, People's Republic of China; 5 Department of Orthopedics, The Second Hospital of Jilin University, Changchun, People's Republic of China Correspondence: He Liu, Department of Orthopedics, The Second Hospital of Jilin University, Changchun, 130041, People's Republic of China, Email From a clinical perspective, local anesthetics have rather widespread application in regional blockade for surgery, postoperative analgesia, acute/chronic pain control, and even cancer treatments. However, a number of disadvantages are associated with traditional local anesthetic agents as well as routine drug delivery administration ways, such as neurotoxicity, short half-time, and non-sustained release, thereby limiting their application in clinical practice. Successful characterization of drug delivery systems (DDSs) for individual local anesthetic agents can support to achieve more efficient drug release and prolonged duration of action with reduced systemic toxicity. Different types of DDSs involving various carriers have been examined, including micromaterials, nanomaterials, and cyclodextrin. Among them, nanotechnology-based delivery approaches have significantly developed in the last decade due to the low systemic toxicity and the greater efficacy of non-conventional local anesthetics. Multiple nanosized materials, including polymeric, lipid (solid lipid nanoparticles, nanostructured lipid carriers, and nanoemulsions), metallic, inorganic non-metallic, and hybrid nanoparticles, offer a safe, localized, and long-acting solution for pain management and tumor therapy. This review provides a brief synopsis of different nano-based DDSs for local anesthetics with variable sizes and structural morphology, such as nanocapsules and nanospheres. Recent original research utilizing nanotechnology-based delivery systems is particularly discussed, and the progress and strengths of these DDSs are highlighted. A specific focus of this review is the comparison of various nano-based DDSs for local anesthetics, which can offer additional indications for their further improvement. All in all, nano-based DDSs with unique advantages provide a novel direction for the development of safer and more effective local anesthetic formulations. Keywords: local anesthetics, pain, drug delivery system, nanotechnology, nanocarriers, nanoparticles Local anesthetics serve as one of the most common strategies for anesthesia and analgesia during and after surgery, and induce temporary loss of pain through inhibiting transmission of nerve impulses. 1–3 In combination with immunotherapy, local anesthetics have been shown to exert a synergistic effect on cancer, which is similar to oncolytic treatments when targeted to lesional areas, thereby extending their traditional indications. 4,5 While local anesthetics have been extensively applied in the clinic over the past century, two major disadvantages, specifically, neurotoxicity and short half-time, significantly limit their clinical utility. 6,7 The majority of drugs, such as bupivacaine, lidocaine, and ropivacaine, have considerable clinical impacts but are associated with relatively short duration of action, and toxicity-induced neurological and cardiovascular manifestations. 8 Of note, many local anesthetics can induce hypertensive events and even serious outcomes, including refractory cardiac dysfunction, dysrhythmias, and prearrest situations due to their systemic toxicity. 9 In addition to toxicity, short duration of action is the other drawback, which needs to be improved for some particular conditions, as exemplified by intravertebral anesthesia. To eliminate or minimize these side-effects, drug delivery systems (DDSs) encapsulating local anesthetic agents have been developed for continuous release, which ensure that drug release is considerably slower and analgesia is maintained for a prolonged period with lower associated neurotoxicity. 10,11 In general, an effective DDS requires the following features: reduced tissue reaction, efficient drug release capability, good stability, and steady degradation rates of a biodegradable carrier. 12,13 A number of DDSs for local anesthetics have been developed fo -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal